Human in Motion Robotics
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Debt | ||
N/A | Seed | ||
$260k | Grant | ||
$2.7m | Seed | ||
$300k | Grant | ||
* | $10.0m | Series A | |
Total Funding | €12.1m |
Related Content
Recent News about Human in Motion Robotics
EditHuman in Motion Robotics (HMR) specializes in developing advanced exoskeleton technology designed to assist individuals with lower extremity motor deficits. Operating in the healthcare and rehabilitation market, HMR's core product, XoMotion, is a next-generation exoskeleton platform that mimics the physiological motion of the lower extremities, allowing users to perform complex mobility tasks hands-free. The company serves patients with mobility impairments, rehabilitation centers, and clinical specialists. HMR's business model includes selling and leasing their exoskeleton devices to rehabilitation centers and, eventually, to individual consumers for personal use. Revenue is generated through direct sales, leasing agreements, and potential future clinical trial collaborations. The company is headquartered in Vancouver, Canada, with additional offices in Seoul, South Korea, and aims to revolutionize mobility solutions for millions worldwide.
Keywords: exoskeleton, mobility, rehabilitation, lower extremity, hands-free, XoMotion, healthcare, robotics, clinical trials, Vancouver.